Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Oral estrogens were the treatment of choice for carcinoma of the prostate for over four decades ... advantage of giving protection against the effects of andropause (similar to the female ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

As with many cancers, early treatment is associated with not only better outcomes but a reduction in treatment-related side effects. Prostate cancer is the second most common cancer in men in the U.S.

3, 2025 — Much of our knowledge of the protein PD-1, a leading cancer treatment ... Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT ... patients with metastatic hormone-sensitive prostate cancer (mHSPC) and will be ...

Speak with your doctor about your concerns and how you can manage or prevent some side effects or complications. Dialysis is a lifesaving treatment for people with kidney failure. But when you ...